Loss of TER was significantly related to the baseline TER (Spearman ρ = −0.62; p < 0.001) but not to the cumulative activities Acum, the number of treatment cycles, the treatment duration, the patient age, prior chemotherapy, hypertension, diabetes mellitus, antihypertensive medication, intake of analgesics or somatostatin analogues (Table 1). Here, SST is linked to diabetes mellitus.